Monitus Research has two missions:
To facilitate financing and secure effective early exit.

We are independent and bespoke; so are your requirements.
For a confidential discussion about your future options, email us.

It is never too early to discuss investment or an exit.


Our client base is small; it revolves around you. So we get to know each client, their product and its science. We investigate, question and assess. Using proprietary software, we calculate your product’s true current and potential adjusted net present value. We invest in your future.

In-depth international research identifies interested parties and a successful exit secured for you and the founding investors.


Financing and an effective early exit depends on the skills of the people brokering the deal, rather than the size of the investment firm instructed.

At Monitus Research, you will only ever deal with directors.

The people you instruct are the people you will deal with; the people who will invest in your financing and secure your exit. In both transactions, we will negotiate the best possible outcome.

Between the directors we have 25 years of investment banking expertise and 30 years of pharma and biotech experience. We fully understand your science and your aspirations.

And we only invest in life science companies.

With over 50 years of combined experience, we are uniquely placed to invest in your company and deliver a profitable exit.

We are traditional; we value personal contacts
and opinions over mathematical algorithms.

Your successful financing and effective
early exit our only concerns.



©2024 Monitus Research Ltd. All rights reserved. Registered in England & Wales 08866457. Registered office: 50 High Street, Haddenham, Buckinghamshire HP17 8ET.

site by browngraphics.co.uk